Gary J. Kelloff connects Colorectal cancer with Cancer prevention in his study. Gary J. Kelloff performs multidisciplinary study in Cancer prevention and Colorectal cancer in his work. His research on Pathology frequently connects to adjacent areas such as Micronutrient. His Pathology research extends to Micronutrient, which is thematically connected. In his papers, Gary J. Kelloff integrates diverse fields, such as Cancer and Oncology. In his papers, Gary J. Kelloff integrates diverse fields, such as Oncology and Cancer. Internal medicine is closely attributed to Aspirin in his work. His work on Internal medicine expands to the thematically related Aspirin. Aberrant crypt foci is often connected to Colonic disease in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Gideon Steinbach;Patrick M. Lynch;Robin K S Phillips;Marina H. Wallace.
The New England Journal of Medicine (2000)
Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer
Toshihiko Kawamori;Ronald Lubet;Vernon E. Steele;Gary J. Kelloff.
Cancer Research (1999)
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher.
Clinical Cancer Research (2005)
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Russell F. Jacoby;Karen Seibert;Carolyn E. Cole;Gary Kelloff.
Cancer Research (2000)
I‐SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
AD Barker;CC Sigman;GJ Kelloff;NM Hylton.
Clinical Pharmacology & Therapeutics (2009)
Chemoprevention of Colon Cancer by Specific Cyclooxygenase-2 Inhibitor, Celecoxib, Administered during Different Stages of Carcinogenesis
Bandaru S. Reddy;Yoshinobu Hirose;Ronald Lubet;Vernon Steele.
Cancer Research (2000)
Progress in Cancer chemoprevention : Development of diet-derived chemopreventive agents
Gary J. Kelloff;James A. Crowell;Vernon E. Steele;Ronald A. Lubet.
Journal of Nutrition (2000)
Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
Charles W. Boone;Gary J. Kelloff;Winfred E. Malone.
Cancer Research (1990)
Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia
Joyce A. O’Shaughnessy;Gary J. Kelloff;Gary B. Gordon;Andrew J. Dannenberg.
Clinical Cancer Research (2002)
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Chinthalapally V. Rao;Abraham Rivenson;Barbara Simi;Edith Zang.
Cancer Research (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: